Kate Rosenbluth, PhD, is the Founder & Chief Scientific Officer of Cala Health, a bioelectronic medicines company transforming the standard of care for chronic disease. The company’s wearable neuromodulation therapies merge innovations in neuroscience and technology. Prior to spinning Cala out from the Stanford Biodesign fellowship, she developed cutting-edge neurotherapies with Brainlab, Autonomic Technologies, and Genentech, and completed a Postdoctoral Fellowship at UCSF in Neurosurgery following her PhD in Bioengineering at UC Berkeley and UCSF.

Kate has authored more than 60 patents and peer-reviewed publications. She is a perpetual student and committed educator in innovation leadership and healthcare. Kate currently serves on the McKinsey Women’s Executive Roundtable and the Strategy Group of the Center for Healthcare Innovation. Kate shares her insights on pursuing meaningful innovation despite the volatile landscape of startups in Silicon Valley.